Pubblicazioni

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy

2023 - ADVANCES IN THERAPY

Breccia, Massimo; Chiodi, Francesca; Nardozza, Aurelio Pio; Valsecchi, Diletta; Perrone, Valentina; Sangiorgi, Diego; Giacomini, Elisa; Rendace, Maria Chiara; Coco, Paola; Premoli, Eleonora; Degli Esposti, Luca

Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

2021 - BLOOD

Puzzolo, M. C.; Radice, G.; Peragine, N.; de Propris, M. S.; Mariglia, P.; Vignetti, M.; Vitale, A.; Bassan, R.; Annunziata, M.; Gaidano, G.; Rambaldi, A.; Chiaretti, S.; Guarini, A.; Foa, R.

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Dasatinib-Blinatumomab for Ph-Positive ALL. Reply

2021 - NEW ENGLAND JOURNAL OF MEDICINE

FoÃ , Robin; Chiaretti, Sabina

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge

2021 - JOURNAL OF CLINICAL MEDICINE

Iurlo, Alessandra; Cattaneo, Daniele; Bucelli, Cristina; Breccia, Massimo

Effect of Comorbidities on Response Outcomes with First-Line Tyrosine Kinase Inhibitors (TKIs), Dasatinib Versus Imatinib, in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Exploratory Post Hoc Analysis of DASISION

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Breccia, Massimo; Mauro, Michael; Jabbour, Elias; Saglio, Giuseppe; Jimenez-Velasco, Antonio; le Coutre, Philipp; Degutis, Irene; Khan, Wasiulla; Sy, Oumar; Swanink, Rene; Cortes, Jorge E.

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study

2021 - ACTA ONCOLOGICA

Stagno, Fabio; Breccia, Massimo; Annunziata, Mario; Trawinska, Malgorzata Monika; Iurlo, Alessandra; Sgherza, Nicola; Fava, Carmen; Gozzini, Antonella; Luciano, Luigiana; Carmosino, Ida; Bonifacio, Massimiliano; Sora, Federica; Crescenzi, Sabrina Leonetti; Crugnola, Monica; Gugliotta, Gabriele; Galimberti, Sara; Bucelli, Cristina; Colafigli, Gioia; Feo, Costanzo; Tiribelli, Mario; Mauro, Endri; Rossi, Antonella Russo; Guarini, Attilio; Abruzzese, Elisabetta; Rosti, Gianantonio; Di Raimondo, Francesco; Latagliata, Roberto

Src family kinases as therapeutic targets in advanced solid tumors: What we have learned so far

2020 - CANCERS

Martellucci, S.; Clementi, L.; Sabetta, S.; Mattei, V.; Botta, L.; Angelucci, A.

Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults

2020 - NEW ENGLAND JOURNAL OF MEDICINE

Foa, R.; Bassan, R.; Vitale, A.; Elia, L.; Piciocchi, A.; Puzzolo, M. -C.; Canichella, M.; Viero, P.; Ferrara, F.; Lunghi, M.; Fabbiano, F.; Bonifacio, M.; Fracchiolla, N.; Di Bartolomeo, P.; Mancino, A.; De Propris, M. -S.; Vignetti, M.; Guarini, A.; Rambaldi, A.; Chiaretti, S.

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

2020 - LEUKEMIA

Efficace, Fabio; Stagno, Fabio; Iurlo, Alessandra; Breccia, Massimo; Cottone, Francesco; Bonifacio, Massimiliano; Abruzzese, Elisabetta; Castagnetti, Fausto; Caocci, Giovanni; Crugnola, Monica; Capodanno, Isabella; Martino, Bruno; Tiribelli, Mario; Patriarca, Andrea; Gozzini, Antonella; Pregno, Patrizia; Saussele, Susanne; Cascavilla, Nicola; Fozza, Claudio; Bergamaschi, Micaela; Binotto, Gianni; Vignetti, Marco; Rosti, Gianantonio

Relationship Between High Body Mass Index (BMI) and Treatment Outcomes in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Dasatinib or Imatinib: Retrospective Analysis of the Phase 3 DASISION Trial

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Breccia, Massimo; Cortes Jorge, E.; Shah Neil, P.; Saglio, Giuseppe; Jimenez-Velasco, Antonio; Le Coutre, Philipp; Brun, Alexander; Degutis, Irene; Bathena, Sai; Sy, Oumar; Jabbour, Elias

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

2019 - THE NEW ENGLAND JOURNAL OF MEDICINE

Hughes, T. P.; Mauro, M. J.; Cortes, J. E.; Minami, H.; Rea, D.; Deangelo, D. J.; Breccia, M.; Goh, Y. -T.; Talpaz, M.; Hochhaus, A.; le Coutre, P.; Ottmann, O.; Heinrich, M. C.; Steegmann, J. L.; Deininger, M. W. N.; Janssen, J. J. W. M.; Mahon, F. -X.; Minami, Y.; Yeung, D.; Ross, D. M.; Tallman, M. S.; Park, J. H.; Druker, B. J.; Hynds, D.; Duan, Y.; Meille, C.; Hourcade-Potelleret, F.; Vanasse, K. G.; Lang, F.; Kim, D. -W.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

2019 - HAEMATOLOGICA

Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sora, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe

Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib

2018 - EXPERIMENTAL HEMATOLOGY & ONCOLOGY

Sgroi, V.; Bassanelli, M.; Roberto, M.; Iannicelli, E.; Porrini, R.; Pellegrini, P.; Tafuri, A.; Marchetti, P.

Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events

2018 - ANNALS OF HEMATOLOGY

Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; FoÃ , Robin; Breccia, Massimo

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib

2017 - CHEMOTHERAPY

Vigna, E; Martino, B; Bacci, F; Recchia, Ag; Mendicino, F; Morelli, R; Mauro, Fr; Musolino, C; Greco, R; Lucia, E; Sabattini, E; Morabito, F; Gentile, M.

Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

2017 - HEALTH AND QUALITY OF LIFE OUTCOMES

Breccia, Massimo; Baccarani, Michele; Rosti, Gianantonio; Cottone, Francesco; Cannella, Laura; Guilhot, FranÃ§ois; Vignetti, Marco; Efficace, Fabio